United States - English - NLM (National Library of Medicine)

bryant ranch prepack - fentanyl (unii: uf599785jz) (fentanyl - unii:uf599785jz) - fentanyl transdermal system is indicated for the management of pain in opioid-tolerant patients, severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. patients considered opioid-tolerant are those who are taking, for one week or longer, at least 60　mg morphine per day, 25 mcg transdermal fentanyl per hour, 30　mg oral oxycodone per day, 8　mg oral hydromorphone per day, 25 mg oral oxymorphone per day, 60 mg oral hydrocodone per day, or an equianalgesic dose of another opioid. limitations of use - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release/long-acting opioid formulations [see warnings and precautions (5.1)] , reserve fentanyl transdermal system for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be

United States - English - NLM (National Library of Medicine)

heritage pharmaceuticals inc. - diflunisal (unii: 7c546u4den) (diflunisal - unii:7c546u4den) - carefully consider the potential benefits and risks of diflunisal tablets and other treatment options before deciding to use diflunisal tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). diflunisal tablets are indicated for acute or long-term use for symptomatic treatment of the following: - mild to moderate pain - osteoarthritis - rheumatoid arthritis diflunisal tablets are contraindicated in patients with known hypersensitivity to diflunisal or the excipients (see description ). diflunisal tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic/analphylactoid reactions to nsaids have been reported in such patients (see warnings, anaphylactic/anaphylactoid reactions and precautions, preexisting asthma ). in the setting of coronary artery bypass graft (cabg) surgery (see warnings ).

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - iron sucrose - solution for injection - iron sucrose 20 mg/ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - ferrovin is indicated for the treatment of iron deficiency in the following indications:• where there is a clinical need for a rapid iron supply,• in patients who cannot tolerate oral iron therapy or who are non-compliant,• in active inflammatory bowel disease where oral iron preparations are ineffective,• in chronic kidney disease when oral iron preparations are less effective.the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. hb (haemoglobin),serum ferritin, tsat (transferrin saturation), serum iron, etc.).

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios hipra s.a. - gleptoferron - solution for injection - 200 milligram(s)/millilitre - iron, parenteral preparations - pigs - vitamins and minerals

Ireland - English - HPRA (Health Products Regulatory Authority)

pharmacosmos a/s - iron - solution for injection/infusion - 100 milligram(s)/millilitre - iron, parenteral preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

pharmacosmos a/s - iron (iii) hydroxide dextran complex - solution for injection/infusion - 50 milligram(s)/millilitre - iron, parenteral preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

pharmacosmos a/s - iron (iii) - solution for injection - 50 milligram(s)/millilitre - iron, parenteral preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

vifor france - iron carboxymaltose - dispersion for injection/infusion - 50 iron milligram(s)/millilitre - iron, parenteral preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

pharmacosmos a/s - iron - solution for injection/infusion - 100 milligram(s)/millilitre - iron, parenteral preparations

Singapore - English - HSA (Health Sciences Authority)

vifor pharma asia pacific pte. ltd. - iron eqv iron sucrose - injection - 100 mg/5 ml - iron eqv iron sucrose 100 mg/5 ml